APA (7th ed.) Citation

YG, T., F, K., HH, H., K, C., KJ, T., WKO, L., . . . JSP, Y. (2021). Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry. The Prostate, 81(4), 242. https://doi.org/10.1002/pros.24100

Chicago Style (17th ed.) Citation

YG, Tan, Khalid F, Huang HH, Chen K, Tay KJ, Lau WKO, Cheng CWS, Ngo NT, and Yuen JSP. "Prostatic Ductal Adenocarcinoma Variant Predicts Worse Pathological and Oncological Outcomes: Insight from over 1000 Consecutive Patients from a Large Prospective Uro-oncology Registry." The Prostate 81, no. 4 (2021): 242. https://doi.org/10.1002/pros.24100.

MLA (9th ed.) Citation

YG, Tan, et al. "Prostatic Ductal Adenocarcinoma Variant Predicts Worse Pathological and Oncological Outcomes: Insight from over 1000 Consecutive Patients from a Large Prospective Uro-oncology Registry." The Prostate, vol. 81, no. 4, 2021, p. 242, https://doi.org/10.1002/pros.24100.